Polymorphs of a c-met/hgfr inhibitor

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2706430

This invention relates to polymorphs of 2-[4-(3-Quinolin-6-ylmethyl-3H- [1,2,3]triazolo[4,5-b]pyrazin-5-yl)-pyrazol-1-yl]-ethanol that are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to compositions including such salts and polymorphs, and to methods of using such compositions in the treatment of abnormal cell growth in mammals, especially humans.

La présente invention concerne des polymorphes du 2-[4-(3-quinoléin-6-ylméthyl-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-pyrazol-1-yl]-éthanol qui sont utiles dans le traitement d'une croissance cellulaire anormale, tel qu'un cancer, chez des mammifères. Cette invention concerne également des compositions renfermant de tels sels et polymorphes et des procédés d'utilisation de telles compositions dans le traitement d'une croissance cellulaire anormale chez des mammifères, spécialement des êtres humains.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Polymorphs of a c-met/hgfr inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polymorphs of a c-met/hgfr inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphs of a c-met/hgfr inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1364742

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.